FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37040458> ?p ?o ?g. }

• Q37040458 description "article científic" @default.
• Q37040458 description "article scientifique" @default.
• Q37040458 description "articolo scientifico" @default.
• Q37040458 description "artigo científico" @default.
• Q37040458 description "artículu científicu espublizáu en 2010" @default.
• Q37040458 description "bilimsel makale" @default.
• Q37040458 description "scientific article published on January 2010" @default.
• Q37040458 description "vedecký článok" @default.
• Q37040458 description "vetenskaplig artikel" @default.
• Q37040458 description "videnskabelig artikel" @default.
• Q37040458 description "vědecký článek" @default.
• Q37040458 description "wetenschappelijk artikel" @default.
• Q37040458 description "wissenschaftlicher Artikel" @default.
• Q37040458 description "наукова стаття, опублікована в січні 2010" @default.
• Q37040458 description "научни чланак" @default.
• Q37040458 description "مقالة علمية نشرت في يناير 2010" @default.
• Q37040458 name "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 name "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 name "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 type Item @default.
• Q37040458 label "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 label "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 label "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 prefLabel "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 prefLabel "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 prefLabel "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 P1433 Q37040458-F17343BE-BA82-407D-83AE-EC883F65768D @default.
• Q37040458 P1476 Q37040458-74F8BFC0-59B7-43D5-AC6F-5ECC8B8B1EB3 @default.
• Q37040458 P2093 Q37040458-0611D693-0FF4-40E2-8157-9F951DC1DB04 @default.
• Q37040458 P2093 Q37040458-20B2D47F-DE05-4A87-89C8-C7AADC0D3C36 @default.
• Q37040458 P2093 Q37040458-55384D9C-FAF2-4CD7-AD7B-78BAB08AEA0D @default.
• Q37040458 P2093 Q37040458-787609D6-4C7A-4098-B0AF-CD09174F83CF @default.
• Q37040458 P2093 Q37040458-81BB6AC7-BD6B-4733-8D35-6E4835C31111 @default.
• Q37040458 P2093 Q37040458-8A63A152-CBA2-4A46-AC52-54FFB052319B @default.
• Q37040458 P2093 Q37040458-9FE249F4-0F56-4364-87F8-16E492274FF1 @default.
• Q37040458 P2093 Q37040458-A60F87F2-1F17-47F4-ABFB-6CC02AF2F749 @default.
• Q37040458 P2093 Q37040458-B249CE38-637D-4E23-8499-7306F3F59CE2 @default.
• Q37040458 P2093 Q37040458-BF5283BF-773A-4CBA-A0DB-84C17FF00F66 @default.
• Q37040458 P2093 Q37040458-C0E7CBBE-33EC-43CC-B74B-483018A7B9CF @default.
• Q37040458 P2093 Q37040458-E5650053-3EAF-4119-BF13-5452146D085B @default.
• Q37040458 P2093 Q37040458-F4157ED2-FB1F-44EE-AD2C-044580E79335 @default.
• Q37040458 P2860 Q37040458-0094E010-D95A-4960-9E44-CC797667FF71 @default.
• Q37040458 P2860 Q37040458-01192C38-7BB9-4E8F-A559-511BCF477E90 @default.
• Q37040458 P2860 Q37040458-0E437F08-AD17-4F15-8192-E3C0573358DD @default.
• Q37040458 P2860 Q37040458-1E71713C-ABA5-4739-B74A-0918F97C5C5D @default.
• Q37040458 P2860 Q37040458-360B1426-AFC4-4E85-BAB9-2370AF42D108 @default.
• Q37040458 P2860 Q37040458-3688A7BB-E398-4824-ACA1-B89145DA023B @default.
• Q37040458 P2860 Q37040458-3883BD73-265F-486B-87DB-4D024407CB2E @default.
• Q37040458 P2860 Q37040458-3F4CAA10-B34F-42EF-8D20-D52A06075BD8 @default.
• Q37040458 P2860 Q37040458-4C259368-FCFC-4FC5-BB71-68F3D0D45D4E @default.
• Q37040458 P2860 Q37040458-4D1227CA-9AD4-42C8-BF4C-43F05A13237D @default.
• Q37040458 P2860 Q37040458-50C99C6E-5230-4888-886B-3310FCB725CB @default.
• Q37040458 P2860 Q37040458-53099498-1CBE-45BA-B9A6-9A7A80BF4D54 @default.
• Q37040458 P2860 Q37040458-543DA527-40B2-433E-AA71-489B39018F38 @default.
• Q37040458 P2860 Q37040458-5613BC4D-8899-4068-948F-8BDB335F3B5E @default.
• Q37040458 P2860 Q37040458-5F82CC7B-BA23-40A6-87DC-B39AD2068C1A @default.
• Q37040458 P2860 Q37040458-670C5F45-91F5-4827-A300-D44A225B424B @default.
• Q37040458 P2860 Q37040458-695038B1-17E1-4584-A6EA-CAD3FCC57F7D @default.
• Q37040458 P2860 Q37040458-6AB67CA2-399A-4BE1-A9AD-719118773D2B @default.
• Q37040458 P2860 Q37040458-71164FCF-E368-4192-B23C-460A275B8189 @default.
• Q37040458 P2860 Q37040458-72723FFF-C915-4272-BAD1-89EF069747EF @default.
• Q37040458 P2860 Q37040458-755287C1-D80A-44ED-9CDD-FCA26A5353B0 @default.
• Q37040458 P2860 Q37040458-75746B58-E153-4D6D-A123-C845AAAB2260 @default.
• Q37040458 P2860 Q37040458-7952BF05-C1E4-4C19-813A-C90E11E5831E @default.
• Q37040458 P2860 Q37040458-7FC1F3C1-5EE8-44E3-9EB2-18796E25C7D4 @default.
• Q37040458 P2860 Q37040458-89D24697-AF8D-46E6-9DDC-EE9814B5E21D @default.
• Q37040458 P2860 Q37040458-974BB522-BD51-4B75-BA7D-DDF55692B537 @default.
• Q37040458 P2860 Q37040458-9A0C423D-201F-439F-B653-43B7D14BA5A9 @default.
• Q37040458 P2860 Q37040458-9DE7AFDC-501B-4F3F-9C1B-C882F454112A @default.
• Q37040458 P2860 Q37040458-9F64331A-2E06-48C7-997E-DD76A35E53D4 @default.
• Q37040458 P2860 Q37040458-A62EC0CE-B651-4790-9376-7D930391293C @default.
• Q37040458 P2860 Q37040458-B1DF6350-D0D8-4551-9613-BAB477B5E3F4 @default.
• Q37040458 P2860 Q37040458-B3B77FA4-2BF7-4637-9175-AB1E78BED26C @default.
• Q37040458 P2860 Q37040458-B53452CF-2503-4F85-8DD4-7BE3190F3F93 @default.
• Q37040458 P2860 Q37040458-B99FCEAA-F291-44BF-B655-7E3EF0AC964D @default.
• Q37040458 P2860 Q37040458-CACAA07F-3EBA-4824-99AC-325587F5FEE4 @default.
• Q37040458 P2860 Q37040458-E0DA3241-6854-4CC5-A743-C83040A1B4C0 @default.
• Q37040458 P2860 Q37040458-E47BA911-CB11-4491-BD83-1E79B43F4EAC @default.
• Q37040458 P2860 Q37040458-E838379B-6D93-4CCC-84D0-74722E18C18F @default.
• Q37040458 P2860 Q37040458-ECB17CA4-3BC4-405E-BE1D-4765B803B8C7 @default.
• Q37040458 P2860 Q37040458-F66B6333-4A95-4230-AC26-8596BF4A4B01 @default.
• Q37040458 P2860 Q37040458-FA6B95DB-19F8-412D-AA81-C7C2BC078F9C @default.
• Q37040458 P304 Q37040458-0FF2F569-21EF-421B-8E97-7B6FD035DA07 @default.
• Q37040458 P31 Q37040458-ACB39572-3533-42AD-B8A0-F91B87B25C94 @default.
• Q37040458 P356 Q37040458-9E7E60B9-75B9-427A-8411-0A851BFA47E6 @default.
• Q37040458 P433 Q37040458-D1645546-0415-473C-BDD5-CF51F4344047 @default.
• Q37040458 P478 Q37040458-030811C2-E674-4C03-811D-FF91B9CE320D @default.
• Q37040458 P577 Q37040458-8E9259DB-1255-4608-AAAA-1024272FBB7D @default.
• Q37040458 P5875 Q37040458-FBE2BF1A-9666-43D1-9F3D-3F2AE5377CEF @default.
• Q37040458 P698 Q37040458-85867F78-87D6-417E-93A1-CC462C504565 @default.
• Q37040458 P8608 Q37040458-9D4AB92D-CF23-4D9F-8604-C560D1B48849 @default.
• Q37040458 P932 Q37040458-548751B0-473E-474B-86E1-29B9947B8DB8 @default.
• Q37040458 P356 J.YMGME.2009.08.003 @default.
• Q37040458 P698 19775921 @default.
• Q37040458 P1433 Q6895949 @default.
• Q37040458 P1476 "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants" @default.
• Q37040458 P2093 "Amy Rosenberg" @default.
• Q37040458 P2093 "Danny Benjamin" @default.
• Q37040458 P2093 "Deeksha Bali" @default.
• Q37040458 P2093 "Dwight Koeberl" @default.

• next